Ahmadi Alireza, Sabri Mohammadreza, Bigdelian Hamid, Dehghan Bahar, Gharipour Mojgan
Assistant Professor, Isfahan Cardiovascular Research Centre, Isfahan Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, Iran.
Professor, Department of Pediatrics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
ARYA Atheroscler. 2014 Jan;10(1):37-40.
Various devices have been recently employed for percutaneous closure of the patent ductus arteriosus (PDA). Although the high effectiveness of device closure techniques has been clearly determined, a few studies have focused on the cost-effectiveness and also postoperative complications of these procedures in comparison with open surgery. The present study aimed to evaluate the clinical outcome and cost-effectiveness of PDA occlusion by Amplatzer and coil device in comparisong with open surgery.
In this cross-sectional study, a randomized sample of 201 patients aged 1 month to 16 years (105 patients with device closure and 96 patients with surgical closure) was selected. The ratio of total pulmonary blood flow to total systemic blood flow, the Qp/Qs ratio, was measured using a pulmonary artery catheter. The cost analysis included direct medical care costs associated with device implantation and open surgery, as well as professional fees. All costs were calculated in Iranian Rials and then converted to US dollars.
There was no statistical difference in mean Qp/Qs ratio before the procedure between the device closure group and the open surgery group (2.1 ± 0.7 versus 1.7 ± 0.6, P = 0.090). The mean measured costs were overall higher in the device closure group than in open closure group (948.87 ± 548.76 US$ versus 743.70 ± 696.91 US$, P < 0.001). This difference remained significant after adjustment for age and gender (Standardized Beta = 0.160, P = 0.031). PDA closure with the Amplatzer ductal occluder (1053.05 ± 525.73 US$) or with Nit-Occlud coils (PFM) (912.73 ± 565.94 US$, P < 0.001) was more expensive than that via open surgery. However, the Cook detachable spring coils device closure (605.65 ± 194.62 US$, P = 0.650) had a non-significant cost difference with open surgery. No event was observed in the device closure group regarding in-hospital mortality or morbidity; however, in another group, 2 in-hospital deaths occurred, two patients experienced pneumonia and seizure, and one suffered electrolyte abnormalities including hyponatremia and hypocalcemia.
Although open surgery seems to be less expensive than device closure technique, because of lower mortality and morbidity, the latter group is more preferable.
近年来,各种装置已被用于经皮闭合动脉导管未闭(PDA)。尽管装置闭合技术的高效性已得到明确证实,但与开放手术相比,很少有研究关注这些手术的成本效益以及术后并发症。本研究旨在评估使用Amplatzer和弹簧圈装置闭合PDA与开放手术相比的临床结局和成本效益。
在这项横断面研究中,选取了201例年龄在1个月至16岁之间的随机样本患者(105例行装置闭合,96例行手术闭合)。使用肺动脉导管测量肺总血流量与体循环总血流量之比,即Qp/Qs比值。成本分析包括与装置植入和开放手术相关的直接医疗费用以及专业费用。所有成本均以伊朗里亚尔计算,然后换算成美元。
装置闭合组和开放手术组术前平均Qp/Qs比值无统计学差异(2.1±0.7对1.7±0.6,P = 0.090)。装置闭合组的平均测量成本总体高于开放闭合组(948.87±548.76美元对743.70±696.91美元,P < 0.001)。在对年龄和性别进行调整后,这种差异仍然显著(标准化β = 0.160,P = 0.031)。使用Amplatzer导管封堵器(1053.05±525.73美元)或Nit-Occlud弹簧圈(PFM)(912.73±565.94美元,P < 0.001)闭合PDA比开放手术更昂贵。然而,使用Cook可脱卸弹簧圈装置闭合(605.65±194.62美元,P = 0.650)与开放手术的成本差异无统计学意义。装置闭合组未观察到院内死亡或发病事件;然而,在另一组中,发生了2例院内死亡,2例患者出现肺炎和癫痫发作,1例患者出现包括低钠血症和低钙血症在内的电解质异常。
尽管开放手术似乎比装置闭合技术成本更低,但由于死亡率和发病率较低,后者更可取。